Background Chordomas are very rare low-grade malignant bone tumors that arise from the
embryonic rests of the notochord. They are characterized by slow growth and long history …

Chordomas are rare primary malignant bone tumors arising from embryonal notochord
remnants of the axial skeleton. Chordomas commonly recur following surgery and …

Chordoma is a rare malignant axial tumour that develops from embryonic remnants of the
notochord. Surgery and irradiation are the standard initial treatment. However, local …

Objective: Unusual or unexpected effect of treatment Background: Chordoma is rare, but
aggressive bone tumor, primarily affecting the axial skeleton. Systemic chemotherapies are …

Chordomas are rare bone tumors with no approved therapy. These tumors express several
activated tyrosine kinase receptors, which prompted attempts to treat patients with tyrosine …

Background Chordomas are rare malignant tumours of the axial skeleton and skull base
supposed to arise from cellular remnants of the notochord. These tumours have the potential …

Background Chordoma is a rare malignant tumor of the skull base and axial skeleton, with
an incidence of less than 0.1/100,000 per year. Patients with advanced chordoma have a …

Chordomas are rare tumors arising from the axial skeleton. The disease is characterized by
slow local growth, frequent local recurrences, and rare systemic spread. Surgery and local …

Chordomas are rare primary bone tumors that occur along the neuraxis. Primary treatment is
surgery, often followed by radiotherapy. Treatment options for patients with recurrence are …

Chordomas, derived from undifferentiated notochordal remnants, represent less than 4% of
bone primary tumors. Despite surgery followed by radiotherapy, local and metastatic …